Opportunities for <i>Helicobacter pylori</i> Eradication beyond Conventional Antibiotics
<i>Helicobacter pylori</i> (<i>H. pylori</i>) is a bacterium known to be associated with a significant risk of gastric cancer in addition to chronic gastritis, peptic ulcer, and MALT lymphoma. Although only a small percentage of patients infected with <i>H. pylori</i...
Saved in:
| Main Authors: | Camilia Metadea Aji Savitri, Kartika Afrida Fauzia, Ricky Indra Alfaray, Hafeza Aftab, Ari Fahrial Syam, Masrul Lubis, Yoshio Yamaoka, Muhammad Miftahussurur |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/12/10/1986 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Mechanisms of Biofilm Formation in <i>Helicobacter pylori</i>
by: Kartika Afrida Fauzia, et al.
Published: (2024-10-01) -
Cytoprotection of the Gastric Mucosa and Eradication Therapy of <i>Helicobacter Pylori</i> Infection: Points of Conjugation
by: A. S. Trukhmanov, et al.
Published: (2025-06-01) -
Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01) -
Comparison of Amoxicillin Administered Twice versus Four Times a Day in First-Line <i>Helicobacter pylori</i> Eradication Using Tegoprazan, Clarithromycin, and Bismuth: A Propensity Score Matching Analysis
by: Jun-Hyung Cho, et al.
Published: (2024-09-01) -
Efficacy and Safety of Modified Bismuth Quadruple Therapy for First-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Jun-Hyung Cho, et al.
Published: (2025-02-01)